Familial Hypercholesterolemia - Heterozygous
Metabolic·MeSH: Hypercholesterolemia
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| inclisiran | Novartis AG (NVS) |
Phase 4(1)
| Drug | Company |
|---|---|
| Inclisiran | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Familial Hypercholesterolemia - Heterozygous?
BioSniper tracks 2 drugs in development for Familial Hypercholesterolemia - Heterozygous across 1 company.
How many clinical trials target Familial Hypercholesterolemia - Heterozygous?
There are 1 clinical trial targeting Familial Hypercholesterolemia - Heterozygous tracked by BioSniper.
Deep-dive into Familial Hypercholesterolemia - Heterozygous
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis